How Do Regulatory Discrepancies Affect Access to Specialized Hormonal Therapies in China?
Regulatory discrepancies in China significantly impede access to specialized hormonal therapies through stringent approvals, import barriers, and restrictive prescribing guidelines.
HRTioJuly 21, 2025